Achilles Therapeutics, a biopharmaceutical company launched in 2016, based on work led by Professor Charles Swanton of UCL and the Francis Crick Institute, has [...]
AstronauTx, a new biotech company building upon research from the Alzheimer’s Research UK UCL Drug Discovery Institute (DDI), has received £6.5million investmen [...]
On the 27th June UCLB hosted its Annual Summer Party alongside the backdrop of UCL’s historical Portico building. The evening provided a great opportunity for f [...]
British fashion designer Sir Paul Smith has given a personal donation to support two UCL artists to ‘dress’ the university’s iconic Wilkins Building and complet [...]
Senceive Ltd, a spinout from the Department of Electronic and Electrical Engineering, has been awarded the SME of the Year accolade at this year’s Rail Partners [...]
Congratulations to UCL spinout Echopoint who received the Innovators Award at last night’s UCL Awards for Innovation & Enterprise 2019. Adrien Desjardins an [...]
Parkwalk and the UCL Technology Fund are leading a £750k investment into Phasecraft, a pioneering quantum computing company, along with the London Co-Investment [...]
NHS England (NHSE) has announced that it will offer an online portal to people with type 2 diabetes to help them manage their condition via a first of its kind [...]
Today Syncona announced the foundation of Quell Therapeutics (Quell), a new cell therapy company, with a £35 million commitment in a Series A financing of which [...]
Portico Ventures Programme spinout Odin Vision, which is using space technology to improve the early detection and diagnosis of bowel cancer, has secured £1 mil [...]
